Amir Ibrahim, Cpa, MBA
About Amir Ibrahim, Cpa, MBA
Amir Ibrahim, CPA, MBA, is the Executive Director of US Hematology Finance at Bristol Myers Squibb, with extensive experience in international finance and senior roles at Celgene, BD, and Pfizer.
Company
Amir Ibrahim is currently working at Bristol Myers Squibb, serving as the Executive Director of US Hematology Finance. This involves overseeing financial strategies and operations within the US Hematology sector.
Title
Amir Ibrahim holds the position of Executive Director of US Hematology Finance at Bristol Myers Squibb. His role includes managing financial operations and developing strategic financial initiatives for the company's hematology division in the United States.
Education and Expertise
Amir Ibrahim holds an MBA in Finance from Fairleigh Dickinson University, which he pursued from 2007 to 2012, and a BS in Accounting from Rutgers, The State University of New Jersey-Newark, obtained from 1992 to 1996. His educational background is complemented by extensive professional experience in both accounting and finance.
Professional Background
Amir Ibrahim started his career as a Senior Auditor at Nisivoccia LLP Accounting, Audit & Business Advisory from 1997 to 1999. He later joined Pfizer, where he held various roles, including Director - International Treasury and Director - Corporate Accounting. Following Pfizer, he worked at BD as Manager of Accounting & Reporting, Senior Manager of Corporate Development, and Finance Manager for Injection Systems. In Celgene, he served as Senior Director - Global Hematology Finance and Senior Director - Finance and Business Operations in Japan.
International Finance Experience
Amir Ibrahim has a notable international finance background, having worked in Tokyo, Japan, as Senior Director - Finance and Business Operations for Celgene from 2017 to 2020. This role involved overseeing financial operations and strategic business initiatives in Japan.